These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1794616)

  • 1. Human retroviruses and herpesviruses: problems and solutions in safety testing of biologicals.
    Onions D; Lees G
    Dev Biol Stand; 1991; 75():145-58. PubMed ID: 1794616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of retroviruses in biologicals manufactured for human use.
    Hilfenhaus J; Gregersen JP; Müller H; Nowak T; Pranter W
    Dev Biol Stand; 1991; 75():159-69. PubMed ID: 1794617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of removal of human retroviruses.
    Marcus-Sekura CJ
    Dev Biol Stand; 1991; 75():133-43. PubMed ID: 1794615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of quantitative PCR assays for biologicals: quality and safety evaluation.
    Xu Y; Brorson K
    Dev Biol (Basel); 2003; 113():89-98. PubMed ID: 14620857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cell substrates for the production of biologicals: Revision of WHO recommendations. Report of the WHO Study Group on Cell Substrates for the Production of Biologicals, 22-23 April 2009, Bethesda, USA.
    Knezevic I; Stacey G; Petricciani J; Sheets R;
    Biologicals; 2010 Jan; 38(1):162-9. PubMed ID: 19818645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of purification procedures for removing and/or inactivating viruses in biologicals: points to consider.
    Vicari G
    Dev Biol Stand; 1991; 75():227-32. PubMed ID: 1794625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of removal of human retroviruses.
    Marcus-Sekura CJ
    Dev Biol Stand; 1992; 76():215-23. PubMed ID: 1478339
    [No Abstract]   [Full Text] [Related]  

  • 8. Introduction to the issues: detection of retroviruses and associated risks.
    Marcus-Sekura CJ
    Dev Biol Stand; 1992; 76():137-40. PubMed ID: 1478334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroviral insertion into herpesviruses: discovery and implications.
    Kung HJ; Kamil J; Witter R; Davidson I
    Dev Biol (Basel); 2001; 106():223-8; discussion 228-9, 253-63. PubMed ID: 11761235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methodological aspects of the validation of purification procedures of human/animal-derived products to remove unconventional slow viruses.
    Pocchiari M
    Dev Biol Stand; 1991; 75():87-95. PubMed ID: 1794633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk reduction in biotherapeutic products.
    Ill CR; Dehghani H
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):296-304. PubMed ID: 19333875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified single-tube one-step product-enhanced reverse transcriptase (mSTOS-PERT) assay with heparin as DNA polymerase inhibitor for specific detection of RTase activity.
    Fan XY; Lü GZ; Wu LN; Chen JH; Xu WQ; Zhao CN; Guo SQ
    J Clin Virol; 2006 Dec; 37(4):305-12. PubMed ID: 16971176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. At what stage should virus inactivation be carried out?
    Dorner F; Barrett PN; Eibl J
    Dev Biol Stand; 1993; 81():137-43. PubMed ID: 8174796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral safety and clearance evaluation--implications for process change and comparability.
    Dinowitz M
    Dev Biol (Basel); 2002; 109():121-6. PubMed ID: 12434921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clearance of viruses and transmissible spongiform encephalopathy agents from biologicals.
    Farshid M; Taffs RE; Scott D; Asher DM; Brorson K
    Curr Opin Biotechnol; 2005 Oct; 16(5):561-7. PubMed ID: 16095899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between virus infection and pathogenicity in humans.
    Agut H; Huraux JM
    Dev Biol Stand; 1991; 75():211-7. PubMed ID: 1794623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of replication competent retrovirus and lentivirus.
    Sastry L; Cornetta K
    Methods Mol Biol; 2009; 506():243-63. PubMed ID: 19110631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Process changes and their effect on process evaluation for viral clearance.
    Marcus-Sekura C
    Dev Biol Stand; 1996; 88():125-30. PubMed ID: 9119123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The polymerase chain reaction (PCR): a valuable method for retroviral detection.
    Sninsky JJ
    Lymphology; 1990 Jun; 23(2):92-7. PubMed ID: 2170779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.